This inventor holds 1 USPTO granted patent. Top assignee: Amano Pharmaceutical Co., Ltd.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Innovations by Jun Yoshida in Glioma Diagnosis
Introduction
Jun Yoshida is an accomplished inventor based in Aichi, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of gliomas. His innovative approach has the potential to enhance the accuracy of glioma diagnosis, which is crucial for effective treatment.
Latest Patents
Jun Yoshida holds a patent for a method titled "Quantitative determination of tenascin as glioma marker." This patent describes a technique for determining the level of tenascin in cerebrospinal fluid samples through immunoassay. The tenascin level serves as a glioma marker, enabling selective diagnosis of gliomas. This advancement is vital for improving patient outcomes in neurology.
Career Highlights
Yoshida is associated with Amano Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in medical diagnostics.
Collaborations
He has collaborated with notable colleagues, including Shigeki Kimura and Kinya Washizu, to further enhance the research and application of his inventions.
Conclusion
Jun Yoshida's work in the field of glioma diagnosis exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for more accurate diagnostic methods, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile